Beximco Pharma declares dividends, EGM approves merger with Infusions
Beximco Pharmaceuticals has declared five percent cash and 25 percent stock dividends for the owners of 55,976,250 shares at its 29th annual general meeting (AGM) Thursday while the extra-ordinary general meeting (EGM) passed the merger of Beximco Pharma with Infusions.
bdnews24.com News Service
bdnews24.com
Published :
01 Jun 2005, 06:00 PM
Updated :
25 Apr 2022, 01:06 AM
Dhaka, June 2 (BDNEWS) - Beximco Pharmaceuticals has declared five percent cash and 25 percent stock dividends for the owners of 55,976,250 shares at its 29th annual general meeting (AGM) Thursday while the extra-ordinary general meeting (EGM) passed the merger of Beximco Pharma with Infusions.
The AGM also approved a plan to raise Tk 3.15 billion from London Stock Exchange through global depository receipt (GDR) on the day.
Regarding the merger of the two, the company said, this would help stimulate its plan of generating Tk 5 billion turnover annually by 2010.
The EGM was held following a High Court order issued last month regarding the merger of the two companies. The company declared its merger plan on May 2 this year.
Chairman of the Board of Directors of the company A S F Rahman presided over the meetings.
The AGM was informed that the company earned a gross profit of Tk 972.11 million and net profit of Tk 294.30 million for the year 2004.
On going to the London Stock Exchange (LSE), the meeting unanimously resolved that the company will issue up to three crore ordinary shares of Tk 10 each worth Tk 300 million for issuing GDRs worth Tk 3.15 billion.
The AGM also resolved that the company's authorised capital to be raised from Tk one billion to Tk two billion.
Vice-chairman of the company Salman F Rahman, directors Iqbal Ahmed, O K Chowdhury, Dr. Abdul Alim Khan, C H Rahman, Barrister Faheemul Huq and Advocate Ahsanul Karim and Company Secretary Mohammad Asad Ullah were present in the meeting.
BDNEWS/1924 hrs